Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.46% | 201.74 | 1.2% | $403.96m | |
| GILD | Gilead Sciences, Inc. | -0.52% | 72.40 | 0.9% | $392.41m | |
| CELG | Celgene Corporation | 0.55% | 87.68 | 1.2% | $341.00m | |
| BIIB | Biogen Inc. | 0.16% | 334.94 | 1.2% | $274.41m | |
| ILMN | Illumina, Inc. | 0.34% | 348.41 | 3.5% | $253.11m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.65% | 383.99 | 2.6% | $208.88m | |
| EXAS | Exact Sciences Corporation | -1.24% | 72.42 | 25.3% | $196.22m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.31% | 176.34 | 1.9% | $160.36m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.49% | 151.61 | 16.4% | $124.26m | |
| A | Agilent Technologies, Inc. | -0.09% | 69.02 | 1.5% | $121.39m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.54% | 118.45 | 2.0% | $108.08m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -0.25% | 93.12 | 9.7% | $95.58m | |
| NKTR | Nektar Therapeutics | -1.26% | 57.58 | 5.6% | $94.76m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.27% | 98.41 | 4.4% | $90.92m | |
| INCY | Incyte Corporation | 0.42% | 67.30 | 2.5% | $88.07m |
Company Profile
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.